NIH clinical trial testing remdesivir plus interferon beta-1a for COVID-19 treatment begins
06/08/2020
The study is anticipated to enroll more than 1,000 hospitalized adults with COVID-19.
The study is anticipated to enroll more than 1,000 hospitalized adults with COVID-19.